Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: Case report

Child and Adolescent Psychiatry and Mental Health

Volumn 5, Issue , 2011, Pages

  Consoli, Angèle ^a   Ronen, Karine ^a   An Gourfinkel, Isabelle ^a   Barbeau, Martine ^a   Marra, Donata ^a   Costedoat Chalumeau, Nathalie ^a   Montefiore, Delphine ^a   Maksud, Philippe ^a   Bonnot, Olivier ^a   Didelot, Adrien ^b   Amoura, Zahir ^a   Vidailhet, Marie ^a   Cohen, David ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Adolescence; Anti NMDA Receptor encephalitis; Malignant catatonia

Indexed keywords

ANTINUCLEAR ANTIBODY; CLONAZEPAM; CREATINE KINASE; CYCLOPHOSPHAMIDE; FLUORINE 18; IMMUNOGLOBULIN; LORAZEPAM; LOXAPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OLANZAPINE; PREDNISONE;

ACUTE DISEASE; ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; BODY DYSMORPHIC DISORDER; CASE REPORT; CATATONIA; CEREBROSPINAL FLUID EXAMINATION; COGNITIVE REHABILITATION; CREATINE KINASE BLOOD LEVEL; DELUSION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSAUTONOMIA; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; EUPHORIA; EXCITEMENT; FEMALE; FEVER; FOLLOW UP; GRAND MAL SEIZURE; HALLUCINATION; HUMAN; HYPERTENSION; HYPOCHONDRIASIS; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; LOGORRHEA; MANIA; MEMORY DISORDER; MUTISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RIGIDITY; SPEECH THERAPY;

EID: 79955849744     PISSN: None     EISSN: 17532000     Source Type: Journal    
DOI: 10.1186/1753-2000-5-15     Document Type: Article

References (25)

1. Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007, 8(6):413-426.
2. Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005, 11(1):37-49. 10.1177/1073858404269012, 15632277.
3. Lynch DR, Anegawa NJ, Verdoorn T, Pritchett DB. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Mol Pharmacol 1994, 45(3):540-545.
4. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10(1):63-74. 10.1016/S1474-4422(10)70253-2, 21163445.
5. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005, 58(4):594-604. 10.1002/ana.20614, 2245881, 16178029.
6. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61(1):25-36. 10.1002/ana.21050, 2430743, 17262855.
7. Sansing LH, Tuzun E, Ko MW, Baccon J, Lynch DR, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007, 3(5):291-296. 1936221, 17479076.
8. Seki M, Suzuki S, Iizuka T, Shimizu T, Nihei Y, Suzuki N, Dalmau J. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 2008, 79(3):324-326. 10.1136/jnnp.2007.136473, 2574536, 18032452.
9. Novillo-Lopez ME, Rossi JE, Dalmau J, Masjuan J. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology 2008, 70(9):728-729. 10.1212/01.wnl.0000305981.53537.d9, 18299525.
10. Nasky KM, Knittel DR, Manos GH. Psychosis associated with anti-N-methyl-D-aspartate receptor antibodies. CNS Spectr 2008, 13(8):699-703.
11. Parratt KL, Allan M, Lewis SJ, Dalmau J, Halmagyi GM, Spies JM. Acute psychiatric illness in a young woman: an unusual form of encephalitis. Med J Aust 2009, 191(5):284-286.
12. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7(12):1091-1098. 10.1016/S1474-4422(08)70224-2, 2607118, 18851928.
13. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66(1):11-18. 10.1002/ana.21756, 2826225, 19670433.
14. Lahutte B, Cornic F, Bonnot O, Consoli A, An-Gourfinkel I, Amoura Z, Sedel F, Cohen D. Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(6):1393-1398. 10.1016/j.pnpbp.2008.02.015, 18417262.
15. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003, 160(7):1233-1241. 10.1176/appi.ajp.160.7.1233, 12832234.
16. Cornic F, Consoli A, Tanguy ML, Bonnot O, Perisse D, Tordjman S, Laurent C, Cohen D. Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study. Schizophr Res 2009, 113(2-3):233-240. 10.1016/j.schres.2009.04.021, 19443182.
17. Marra D, Amoura Z, Soussan N, Haroche J, Consoli A, Ghillami-Dalbin P, Diemert MC, Musset L, Piette JC, Cohen D. Plasma exchange in patients with stuporous catatonia and systemic lupus erythematosus. Psychother Psychosom 2008, 77(3):195-196. 10.1159/000120280, 18332618.
18. Perisse D, Amoura Z, Cohen D, Saintigny P, Mekhloufi F, Mazet P, Piette JC. Case study: effectiveness of plasma exchange in an adolescent with systemic lupus erythematosus and catatonia. J Am Acad Child Adolesc Psychiatry 2003, 42(4):497-499. 10.1097/01.CHI.0000046820.95464.86, 12649638.
19. Collingridge GL, Isaac JT, Wang YT. Receptor trafficking and synaptic plasticity. Nat Rev Neurosci 2004, 5(12):952-962.
20. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999, 20(3):201-225. 10.1016/S0893-133X(98)00060-8, 10063482.
21. Tordjman S, Drapier D, Bonnot O, Graignic R, Fortes S, Cohen D, Millet B, Laurent C, Roubertoux PL. Animal models relevant to schizophrenia and autism: validity and limitations. Behav Genet 2007, 37(1):61-78. 10.1007/s10519-006-9120-5, 17160702.
22. Lee A, Glick DB, Dinwiddie SH. Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis. J Ect 2006, 22(4):267-270.
23. Schimmel M, Bien CG, Vincent A, Schenk W, Penzien J. Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child 2009, 94(4):314-316.
24. Francis A, Fink M, Appiani F, Bertelsen A, Bolwig TG, Braunig P, Caroff SN, Carroll BT, Cavanna AE, Cohen D, et al. Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J Ect 2010, 26(4):246-247. 10.1097/YCT.0b013e3181fe28bd, 21099376.
25. Elia J, Dell ML, Friedman DF, Zimmerman RA, Balamuth N, Ahmed AA, Pati S. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry 2005, 44(11):1145-1150. 10.1097/01.chi.0000179056.54419.5e, 16239863.